31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts
Sonja Althammer, Scott Antonia(Parker Institute for Cancer Immunotherapy), Brandon W. Higgs(Parker Institute for Cancer Immunotherapy), Margaret K. Callahan(Cornell University), Dung T. Le(Johns Hopkins University), Tze Heng Tan, Tobias Wiestler(AstraZeneca (Germany)), Filipo de Braud(University of Milan), Johanna C. Bendell(Dana-Farber Cancer Institute), David I. Quinn(USC Norris Comprehensive Cancer Center), Stéphane Culine(Hôpital Saint-Louis), Matthew H. Taylor(Providence Portland Medical Center), David J. Vaughn(University of Pennsylvania), Winald R. Gerritsen(Amsterdam UMC Location Vrije Universiteit Amsterdam), Patrick A. Ott(Dana-Farber Cancer Institute), Howard Gurney(Radboud University Nijmegen), Ronald de Wit(Erasmus MC Cancer Institute), Xia Li(Nanjing Drum Tower Hospital), Daniel P. Petrylak(Yale University), Toni K. Choueiri(Harvard University), Emiliano Calvo(South Texas Accelerated Research Therapeutics), Markus Puhlmann(The Christie NHS Foundation Trust), Gerd Binning, Nicholas J. Vogelzang(Comprehensive Cancer Centers of Nevada), Jae‐Lyun Lee(Ulsan College), Dean F. Bajorin(Memorial Sloan Kettering Cancer Center), Joseph W. Kim(National Cancer Institute), Rodolfo F. Perini(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yabing Mai(Merck & Co., Inc., Rahway, NJ, USA (United States)), Padmanee Sharma(The University of Texas MD Anderson Cancer Center), Joyce Antal, Lawrence Fong(UCSF Helen Diller Family Comprehensive Cancer Center), Michael A. Morse(Duke Medical Center), Joaquim Bellmunt(Dana-Farber Cancer Institute), Yves Fradet(Centre hospitalier universitaire de Québec), Pavlina Spilliopoulou(Beatson West of Scotland Cancer Centre), Andrea Necchi(Vita-Salute San Raffaele University), Li Shi, Emily Chan(Ghent University Hospital), Guenter Schmidt, Miguel Ángel Climent(Radboud University Nijmegen), Keith E. Steele, Marlon C. Rebelatto(AstraZeneca (Japan)), Dirk Jaeger(Memorial Sloan Kettering Cancer Center), Rathi N. Pillai(Emory University), Ashok Gupta, Xiaoping Jin, Cora N. Sternberg(Cornell University), Koustubh Ranade, Petri Bono(Helsinki University Hospital)
Cited by 17
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
The Immune Landscape of Cancer
|Immunity|2018|6.3k